Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

被引：0
|
作者：
Rajan Ravichandran
Surapaneni Krishna Mohan
Suresh Kumar Sukumaran
Devakumar Kamaraj
Sumetha Suga Daivasuga
Samson Oliver Abraham Samuel Ravi
Sivakumar Vijayaraghavalu
Ramarathnam Krishna Kumar
机构：
[1] MIOT International,Department of Nephrology
[2] Indian Institute of Technology Madras (IITM),Adjunct Faculty
[3] Panimalar Medical College Hospital and Research Institute,Departments of Biochemistry, Molecular Virology and Research
[4] Panimalar Medical College Hospital and Research Institute,Department of General Medicine
[5] Panimalar Medical College Hospital and Research Institute,Departments of Pharmacology and Research
[6] Panimalar Medical College Hospital and Research Institute,Departments of Microbiology and Molecular Virology
[7] Molbio Diagnostics Private Limited,School of Life Sciences
[8] Manipur University,Department of Engineering Design
[9] IITM,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy of oral indomethacin in the treatment of COVID-19 infection; a randomized clinical trial
    Salmasi, Mehrzad
    Pourajam, Samaneh
    Ashrafi, Farzaneh
    Soltaninejad, Forogh
    Amra, Babak
    Ahmadikia, Zeinab
    Torki, Mehdi
    Darakhshandeh, Ali
    IMMUNOPATHOLOGIA PERSA, 2024, 10 (02):
  • [42] Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Gupta, Anil
    Gonzalez-Rojas, Yaneicy
    Juarez, Erick
    Casal, Manuel Crespo
    Moya, Jaynier
    Falci, Diego Rodrigues
    Sarkis, Elias
    Solis, Joel
    Zheng, Hanzhe
    Scott, Nicola
    Cathcart, Andrea L.
    Parra, Sergio
    Sager, Jennifer E.
    Austin, Daren
    Peppercorn, Amanda
    Alexander, Elizabeth
    Yeh, Wendy W.
    Brinson, Cynthia
    Aldinger, Melissa
    Shapiro, Adrienne E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (13): : 1236 - 1246
  • [43] Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial
    Moya, Jaynier
    Temech, Marisol
    Parra, Sergio
    Juarez, Erick
    Hernandez-Loy, Reinaldo
    Gutierrez, Juan C. Moises
    Diaz, Jorge
    Hussain, Rubaba
    Segal, Scott
    Xu, Claire
    Skingsley, Andrew
    Schnell, Gretja
    El-Zailik, Asma
    Sager, Jennifer E.
    Aldinger, Melissa
    Alexander, Elizabeth L.
    Acloque, Gerard
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):
  • [44] Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
    Hinks, Timothy S. C.
    Cureton, Lucy
    Knight, Ruth
    Wang, Ariel
    Cane, Jennifer L.
    Barber, Vicki S.
    Black, Joanna
    Dutton, Susan J.
    Melhorn, James
    Jabeen, Maisha
    Moss, Phil
    Garlapati, Rajendar
    Baron, Tanya
    Johnson, Graham
    Cantle, Fleur
    Clarke, David
    Elkhodair, Samer
    Underwood, Jonathan
    Lasserson, Daniel
    Pavord, Ian D.
    Morgan, Sophie
    Richards, Duncan
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1130 - 1140
  • [45] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial
    Mostafa Kamal Arefin
    S. K. Nurul Fattah Rumi
    A. K. M. Nasir Uddin
    Sultana Sahana Banu
    Mala Khan
    Ahsanul Kaiser
    Joybaer Anam Chowdhury
    Md. Abdullah Saeed Khan
    Mohammad Jahid Hasan
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 2963 - 2967
  • [46] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial
    Arefin, Mostafa Kamal
    Rumi, S. K. Nurul Fattah
    Uddin, A. K. M. Nasir
    Banu, Sultana Sahana
    Khan, Mala
    Kaiser, Ahsanul
    Chowdhury, Joybaer Anam
    Khan, Md Abdullah Saeed
    Hasan, Mohammad Jahid
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 2963 - 2967
  • [47] Hydroxychloroquine and azithromycin as a treatment of Covid-19: results of an open label non-randomized clinical trial
    Boussageon, Remy
    Pouchain, Denis
    Le Roux, Gerard
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2020, (162): : 170 - 171
  • [48] A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
    Chen, Cheng-Pin
    Lin, Yi-Chun
    Chen, Tsung-Chia
    Tseng, Ting-Yu
    Wong, Hon-Lai
    Kuo, Cheng-Yu
    Lin, Wu-Pu
    Huang, Sz-Rung
    Wang, Wei-Yao
    Liao, Jia-Hung
    Liao, Chung-Shin
    Hung, Yuan-Pin
    Lin, Tse-Hung
    Chang, Tz-Yan
    Hsiao, Chin-Fu
    Huang, Yi-Wen
    Chung, Wei-Sheng
    Cheng, Chien-Yu
    Cheng, Shu-Hsing
    PLOS ONE, 2020, 15 (12):
  • [49] Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
    Mancilla-Galindo, Javier
    Kammar-Garcia, Ashuin
    Mendoza-Gertrudis, Maria de Lourdes
    Garcia Acosta, Javier Michael
    Nava Serrano, Yanira Saralee
    Santiago, Oscar
    Torres Vasquez, Miriam Berenice
    Martinez Martinez, Daniela
    Fernandez-Urrutia, Liliana Aline
    Robledo Pascual, Julio Cesar
    Narvaez Morales, Ivan Daniel
    Velasco-Medina, Andrea Aida
    Mancilla-Ramirez, Javier
    Figueroa-Damian, Ricardo
    Galindo-Sevilla, Norma
    FRONTIERS IN MEDICINE, 2023, 10
  • [50] A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
    Seethamraju, Harish
    Yang, Otto O.
    Loftus, Richard
    Ogbuagu, Onyema
    Sammartino, Daniel
    Mansour, Ali
    Sacha, Jonah B.
    Ojha, Sohita
    Hansen, Scott G.
    Arman, Arvin Cyrus
    Lalezari, Jacob P.
    CLINICAL THERAPEUTICS, 2024, 46 (11) : 891 - 899
12345